Rescue PCI
Showing 1 - 25 of 2,791
Myocardial Infarction Trial in Worldwide (Tenecteplase, Clopidogrel, Coronary angiography)
Active, not recruiting
- Myocardial Infarction
- Tenecteplase
- +3 more
-
Liverpool, Australia
- +49 more
Dec 20, 2022
LMN Disease Trial in Assiut, Cairo, Tanta (PCI)
Not yet recruiting
- LMN Disease
- PCI
-
Assiut, Egypt
- +2 more
Jan 18, 2023
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
STEMI - ST Elevation Myocardial Infarction Trial in Shanghai (Thrombolytic, percutaneous coronary stenting)
Recruiting
- STEMI - ST Elevation Myocardial Infarction
- Thrombolytic
- percutaneous coronary stenting
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
May 20, 2022
Coronary Artery Disease, ST-elevation Myocardial Infarction Trial in Stockholm (FFR Treatment Arm, Conservative Treatment Arm)
Active, not recruiting
- Coronary Artery Disease
- ST-elevation Myocardial Infarction
- FFR Treatment Arm
- Conservative Treatment Arm
-
Stockholm, SwedenKarolinska University Hospital
Oct 6, 2021
Acute ST Segment Elevation Myocardial Infarction, Acute Myocardial Infarction, Multi Vessel Coronary Artery Disease Trial in
Active, not recruiting
- Acute ST Segment Elevation Myocardial Infarction
- +2 more
- Angiography guided PCI
- Fractional Flow Reserve (FFR)
-
Paris, FranceFrance
Nov 15, 2021
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in Harbin (immediate stenting group(one-step
Recruiting
- Coronary Artery Disease
- +9 more
- immediate stenting group(one-step strategy)
- deferred stenting group (two-step strategy)
-
Harbin, Heilongjiang, ChinaThe 2nd Affiliated Hospital of Harbin Medical University
Mar 31, 2022
ST Elevation Myocardial Infarction Trial (Pharmacoinvasive strategy, Reduced-dose facilitated PCI strategy)
Not yet recruiting
- ST Elevation Myocardial Infarction
- Pharmacoinvasive strategy
- Reduced-dose facilitated PCI strategy
- (no location specified)
Feb 10, 2021
Acute Myocardial Infarction, Cardiogenic Shock Trial in Paris (VA-ECMO)
Recruiting
- Acute Myocardial Infarction
- Cardiogenic Shock
- VA-ECMO
-
Paris, FranceHôpital Pitié Salpétrière
Oct 11, 2022
Mantle Cell Lymphoma Trial in Hackensack (Lenalidomide, Ibrutinib, Rituximab)
Active, not recruiting
- Mantle Cell Lymphoma
- Lenalidomide
- +2 more
-
Hackensack, New JerseyThe Cancer Center at Hackensack University Medical Center
May 3, 2022
Coronary Artery Disease Trial in Ho Chi Minh City (Percutaneous Coronary Intervention)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Ho Chi Minh City, VietnamUniversity Medical Center
Oct 1, 2023
ST Elevation Myocardial Infarction Trial in Isehara (Percutaneous coronary intervention)
Enrolling by invitation
- ST Elevation Myocardial Infarction
- Percutaneous coronary intervention
-
Isehara, Kanagawa, JapanTokai University Hospital
Nov 21, 2022
International Post-PCI FFR Extended Registry
Completed
- Coronary Disease
- Percutaneous coronary intervention
-
Seoul, Korea, Republic ofBon-Kwon Koo
Jan 28, 2023
STEMI - ST Elevation Myocardial Infarction Trial in Isehara (Excimer laser catheter)
Terminated
- STEMI - ST Elevation Myocardial Infarction
- Excimer laser catheter
-
Isehara, Kanagawa, JapanTokai University School of Medicine
Sep 29, 2022
Percutaneous Coronary Intervention Optimization With Fractional
Completed
- Coronary Artery Disease
- +2 more
- IVUS guided PCI optimization
- +2 more
- (no location specified)
Feb 19, 2023
Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Impact of current PCI techniques/ devices in
Recruiting
- Coronary Disease
- +9 more
- Impact of current PCI techniques/ devices in complex coronary artery lesions
-
Lucerne, SwitzerlandLucerne Heart Centre
Oct 4, 2023
Helicobacter Pylori Infection Trial in Shanghai (Vonoprazan, Bismuth Potassium Citrate, Tetracycline)
Recruiting
- Helicobacter Pylori Infection
- Vonoprazan
- +5 more
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
May 16, 2023
Coronary Artery Disease Trial in Sacramento (device, behavioral, other)
Recruiting
- Coronary Artery Disease
- LiveCare
- +2 more
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center Division of Cardi
Oct 27, 2023
Coronary Artery Disease Trial in Ferrara, Naples (Cangrelor 50 MG)
Not yet recruiting
- Coronary Artery Disease
- Cangrelor 50 MG
-
Ferrara, Italy
- +1 more
Oct 13, 2023
Complex Coronary Lesions Trial in Worldwide (IVUS, Angio)
Recruiting
- Complex Coronary Lesions
- IVUS
- Angio
-
Aalst, Belgium
- +31 more
Nov 24, 2022
Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)
Active, not recruiting
- Coronary Microvascular Dysfunction
- Bivalirudin
- standard heparin
-
Beijing, Beijing, ChinaPeking university first hospital
Aug 1, 2023
Coronary Artery Disease Left Main, Coronary Artery Disease Trial in Seoul (FFR-Guided PCI, Angiography-Guided PCI)
Not yet recruiting
- Coronary Artery Disease Left Main
- Coronary Artery Disease
- FFR-Guided PCI
- Angiography-Guided PCI
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Apr 28, 2023
Identify Patients Undergoing Elective PCI at Risk of Peri-PCI
Recruiting
- Coronary Artery Disease
- Assessment of platelet reactivity
- Troponin measurement
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Nov 15, 2022
STEMI - ST Elevation Myocardial Infarction, Myocardial Infarction, Acute Coronary Syndrome Trial in Mexico City (percutaneous
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- +2 more
- percutaneous coronary intervention (PCI)
-
Mexico City, MexicoInstituto Nacional de Cardiología Ignacio Chávez
Aug 22, 2023
ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)
Recruiting
- ST Elevation Myocardial Infarction
-
Bucheon, Korea, Republic ofSejong General Hospital
Oct 10, 2023